{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T22:48:13Z","timestamp":1783810093696,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.annder.2017.11.005","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T04:01:04Z","timestamp":1512532864000},"page":"116-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Deux observations de granulome annulaire sous anti-PD1"],"prefix":"10.1016","volume":"145","author":[{"given":"R.","family":"Charollais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Aubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Roche-Kubler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Puzenat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2017.11.005_bib0070","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMe1205943","article-title":"Tumor immunotherapy directed at PD-1","volume":"366","author":"Ribas","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2017.11.005_bib0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.det.2015.03.015","article-title":"Granulomatous drug eruptions","volume":"33","author":"Dodiuk-Gad","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.annder.2017.11.005_bib0080","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.chest.2015.10.082","article-title":"Nivolumab induced sarcoid-like granulomatous reaction in a patient with advanced melanoma","volume":"149","author":"Danlos","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.annder.2017.11.005_bib0085","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/annonc\/mdw193","article-title":"Pulmonary sarcoidosis induced by the anti-PD-1\u00a0monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction","volume":"27","author":"Paydas","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annder.2017.11.005_bib0090","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/bjd.14808","article-title":"Pulmonary sarcoid-like granulomatosis induced by nivolumab","volume":"176","author":"Montaudi\u00e9","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2017.11.005_bib0095","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/dth.12380","article-title":"Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy","volume":"29","author":"Mart\u00ednez Lebor\u00e1ns","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2017.11.005_bib0100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/cancers7020821","article-title":"Sarcoidosis in melanoma patients: case report and literature review","volume":"7","author":"Beutler","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.annder.2017.11.005_bib0105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/ajd.12226","article-title":"Dabrafenib-associated necrobiotic granulomatous reaction","volume":"55","author":"Carlos","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.annder.2017.11.005_bib0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaad.2015.03.055","article-title":"Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options","volume":"75","author":"Piette","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2017.11.005_bib0115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.clindermatol.2014.04.012","article-title":"Granulomatous dysimmune reactions (sarcoidosis, granuloma annulare, and others) on differently injured skin areas","volume":"32","author":"Lo Schiavo","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.annder.2017.11.005_bib0120","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/annonc\/mdw125","article-title":"Pulmonary sarcoidosis induced by the anti-PD1\u00a0monoclonal antibody pembrolizumab","volume":"27","author":"Cousin","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annder.2017.11.005_bib0125","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1164\/rccm.201401-0188OC","article-title":"Blockage of the programmed death-1\u00a0pathway restores sarcoidosis CD4 (+) T-cell proliferative capacity","volume":"190","author":"Braun","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.annder.2017.11.005_bib0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/annonc\/mdv623","article-title":"Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper","volume":"27","author":"Champiat","year":"2016","journal-title":"Ann Oncol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963817310268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963817310268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:05:58Z","timestamp":1758971158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963817310268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0151963817310268"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2017.11.005","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deux observations de granulome annulaire sous anti-PD1","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2017.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}